1 |
Choi SE, Sullivan S. Review of economic evaluation studies for drug reimbursement decision. Korean J Health Policy Admin 2005;15(4):1-25. (Korean)
|
2 |
Gagnon JP, Rindress D, Smith MD. Advisory Panel Chairs. Pharmacoeconomics: Identifying the issues Advisory Panel Reports. Princeton: International Society for Pharmacoeconomics and Outcomes Research, 1998. [cited 2008 Feb 20] Available from URL:http://www.ispor. org/ workpaper/adpanel/apr.pdf
|
3 |
Garrison LP Jr, Neumann PJ, Erickson P, Marshall D, Mullins CD. Using real-world data for coverage and payment decisions: The ISPOR Real-World Data Task Force report. Value Health 2007; 10(5): 326-335
DOI
ScienceOn
|
4 |
Raftery J, Roderick P, Stevens A. Potential use of routine databases in health technology assessment. Health Technol Assess 2005; 9(20): 1-106
PUBMED
|
5 |
Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996
|
6 |
Neumann PJ. Using Cost-effectiveness Analysis to Improve Health Care: Opportunities and Barriers. New York: Oxford University Press; 2005. p118-119
|
7 |
Kim JY, Kim BO, Kang DH, Bae HJ, Kim HC, Kim MS, et al. Construction of National Surveillance System for Cardiovascular & Cerebrovascular Diseases. Seoul: Health Insurance Review & Assessment Service; 2006. (Korean)
|
8 |
Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. New York: Oxford University Press; 2006. p. 126-130
|